Numeric Rating News Today

SpringWorks Therapeutics, Inc. announced that four abstracts from the companys portfolio will be presented at the 2024 American Society of Clinical Oncology Annual Meeting being held May 31 to June...

– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation –

"It can be overwhelming because there are many choices but so little time," says Dr Jonathan Silverberg, of George Washington University, Washington, DC.